|
Volumn 19, Issue 6, 2009, Pages 1811-1814
|
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols
|
Author keywords
Antifungal activity; CYP51; Molecular docking; Synthesis; Triazole
|
Indexed keywords
1,2,4 TRIAZOLE DERIVATIVE;
AMPHOTERICIN B;
ANTIFUNGAL AGENT;
FLUCONAZOLE;
FLUCONAZOLE DERIVATIVE;
ITRACONAZOLE;
KETOCONAZOLE;
RAVUCONAZOLE;
STEROL 14ALPHA DEMETHYLASE;
TERBINAFINE;
UNCLASSIFIED DRUG;
VORICONAZOLE;
ANTIFUNGAL ACTIVITY;
ARTICLE;
ASPERGILLUS FUMIGATUS;
CANDIDA ALBICANS;
CONTROLLED STUDY;
CRYPTOCOCCUS NEOFORMANS;
DRUG DESIGN;
DRUG SYNTHESIS;
ENZYME ACTIVE SITE;
HYDROPHOBICITY;
MICROSPORUM GYPSEUM;
MINIMUM INHIBITORY CONCENTRATION;
MOLECULAR DOCKING;
NONHUMAN;
ANTIFUNGAL AGENTS;
CATALYTIC DOMAIN;
CHEMISTRY, PHARMACEUTICAL;
COMPUTER SIMULATION;
CRYSTALLOGRAPHY, X-RAY;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG DESIGN;
FLUCONAZOLE;
FUNGAL PROTEINS;
MICROBIAL SENSITIVITY TESTS;
MODELS, CHEMICAL;
PROPANOLS;
PROTEIN BINDING;
TRIAZOLES;
FUNGI;
|
EID: 61349104868
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2009.01.048 Document Type: Article |
Times cited : (42)
|
References (15)
|